The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Potential role of dose escalation in overcoming acquired resistance to cabozantinib in metastatic renal cell carcinoma (mRCC).
 
Akanksha Sharma
No Relationships to Disclose
 
Roy Elias
No Relationships to Disclose
 
Alana Christie
No Relationships to Disclose
 
Noelle S Williams
Patents, Royalties, Other Intellectual Property - Rodeo Therapeutics
 
Ivan Pedrosa
Stock and Other Ownership Interests - Health Tech International
Honoraria - Dava Oncology
Consulting or Advisory Role - Bayer
Research Funding - Philips Healthcare (Inst); Siemens Healthineers (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of Patents with Philips Healthcare. No royalties received
 
James Brugarolas
Consulting or Advisory Role - Arrowhead Pharmaceuticals; Calithera Biosciences; Exelixis
Research Funding - Arrowhead Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Non-invasive PET tracer to evaluate HIF2alpha (Inst); Patent of HIF-2 biomarker (Inst); Patent pertaining HIF2a resistance mutations (Inst)
Travel, Accommodations, Expenses - Exelixis